Sanjivani Paranteral Limited

Pharmaceutical company manufacturing a wide range of products and providing contract research and manufacturing services.

1994 | Mumbai, Maharashtra (India) | Active
Last Updated:

Sanjivani Paranteral Profile

Key Indicators

  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 11.88 Cr
  • Company Age 30 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 5.50 Cr
  • Satisfied Charges ₹ 192.05 Cr
  • Revenue Growth 52.39%
  • Profit Growth 36.65%
  • Ebitda 46.19%
  • Net Worth 1008.43%
  • Total Assets 106.61%

About Sanjivani Paranteral

Sanjivani Paranteral Limited (SPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 05 October 1994 and has a history of 30 years and seven months. Its registered office is in Mumbai, Maharashtra, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 531569.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 11.88 Cr.

The company currently has active open charges totaling ₹5.50 Cr. The company has closed loans amounting to ₹192.05 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Sanjivani Paranteral Limited India are Pritesh Jain as CFO and Ravikumar Bogam as Company Secretary. Ashwani Khemka, Mrunmai Sarvankar, Monika Singhania, and Two other members serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24300MH1994PLC081752

  • Company No.

    081752

  • Stock Symbol

    BSE : 531569

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    05 Oct 1994

  • Date of AGM

    24 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Sanjivani Paranteral Limited offer?

Sanjivani Paranteral Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Antiviral Drugs.

Company report

Sanjivani Paranteral Limited

Explore comprehensive data for Sanjivani Paranteral Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Sanjivani Paranteral?

Executive Team (3)

NameDesignationAppointment DateStatus
Ashwani Khemka Country flag representing In Managing Director05-Oct-1994Current
Pritesh Jain CFO26-Apr-2024Current
Ravikumar Bogam Company Secretary31-Aug-2024Current

Board Members (4)

NameDesignationAppointment DateStatus
Srivardhan Khemka Country flag representing In Director 24-Mar-2022Current
Mrunmai Sarvankar Country flag representing In Director 31-Mar-2015Current
Monika Singhania Country flag representing In Director 24-Mar-2022Current
Abhay Shah Country flag representing In Director 08-Apr-2024Current

Financial Performance of Sanjivani Paranteral.

Sanjivani Paranteral Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 52.39% increase. The company also saw a substantial improvement in profitability, with a 36.65% increase in profit. The company's net worth Soared by an impressive increase of 1008.43%.

Sanjivani Paranteral revenue growth over time
Sanjivani Paranteral profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
52.39%
Revenue from Operations
53.31%
Total Assets
106.61%
Profit or Loss
36.65%
Net Worth
1008.43%
EBITDA
46.19%

What is the Ownership and Shareholding Structure of Sanjivani Paranteral?

In 2024, Sanjivani Paranteral had a promoter holding of 27.67% and a public holding of 72.33%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹5.50 Cr

Satisfied Charges

₹192.05 Cr

Charges Breakdown by Lending Institutions

  • Others : 5.50 Cr

Latest Charge Details

DateLenderAmountStatus
14 Aug 2024Others₹5.00 MOpen
31 Jul 2024Others₹5.00 CrOpen
26 Jun 2015Others₹4.00 CrSatisfied
26 Dec 2014Others₹2.00 CrSatisfied
14 Oct 2011Others₹1.00 CrSatisfied

How Many Employees Work at Sanjivani Paranteral?

Sanjivani Paranteral has a workforce of 31 employees as of Mar 25, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Sanjivani Paranteral Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sanjivani Paranteral, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjivani Paranteral's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Sanjivani Paranteral

Recent activity within the organization

  • Annual General Meeting

    Sanjivani Paranteral Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records.

  • Director Appointment

    Ravikumar Venkatramuloo Bogam was appointed as a Company Secretary was appointed as a Company Secretary on 31 Aug 2024 & has been associated with this company since 8 months 9 days .

  • Charges

    A charge with Others amounted to Rs. 0.50 Cr with Charge ID 100964677 was registered on 14 Aug 2024.

  • Charges

    A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100971187 was registered on 31 Jul 2024.

  • Director Appointment

    Pritesh Popatlal Jain was appointed as a Cfo was appointed as a Cfo on 26 Apr 2024 & has been associated with this company since 1 year 14 days .

  • Director Appointment

    Abhay Milan Shah was appointed as a Director was appointed as a Director on 08 Apr 2024 & has been associated with this company since 1 year 1 month .

Frequently asked questions

  • What is the Incorporation or founding date of Sanjivani Paranteral Limited?

    Sanjivani Paranteral Limited was incorporated on 05 Oct 1994.

  • What is authorized share capital and paid-up capital of Sanjivani Paranteral Limited?

    The authorized share capital of Sanjivani Paranteral Limited is ₹ 15.00 Cr and paid-up capital is ₹ 11.88 Cr.

  • Who are the current board members & directors of Sanjivani Paranteral Limited?

    Currently 7 directors are associated with Sanjivani Paranteral Limited.

    • Ashwani Anamisharan Khemka
    • Mrunmai Mahendra Sarvankar
    • Monika Amit Singhania
    • Srivardhan Ashwani Khemka
    • Abhay Milan Shah
    • Pritesh Popatlal Jain
    • Ravikumar Venkatramuloo Bogam

  • What is the registered address of Sanjivani Paranteral Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Sanjivani Paranteral Limited is 205 P-N Kothari Indl Estatel B S Marg Bhandup (W) India, Mumbai, Maharashtra, 400078.

  • What is the corporate identification number (CIN) and company number of Sanjivani Paranteral Limited?

    The corporate identification number (CIN) of Sanjivani Paranteral Limited is L24300MH1994PLC081752 and the company number is 081752 as per Ministry of Corporate Affairs (MCA).

  • Is Sanjivani Paranteral Limited registered with any stock exchange in India?

    Yes, Sanjivani Paranteral Limited is registered on Bombay Stock Exchange (BSE).

  • What is the official website of Sanjivani Paranteral Limited?

    The Official website of Sanjivani Paranteral Limited is https://www.sanjivani.co.in

  • What has been the recent revenue trend for Sanjivani Paranteral Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Sanjivani Paranteral Limited has risen by 52.39%.

  • How many employees does Sanjivani Paranteral Limited currently have?

    As Per 2024 financial reports, 31 employees are currently employed by Sanjivani Paranteral Limited.

  • What change has been observed in the net worth of Sanjivani Paranteral Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Sanjivani Paranteral Limited has experienced an upsurge of 1008.43%.

  • What are the total open charges for Sanjivani Paranteral Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Sanjivani Paranteral Limited amount to ₹ 5.50 Cr.

  • When was the last Balance Sheet of Sanjivani Paranteral Limited filed with the ROC?

    The most recent Balance Sheet for Sanjivani Paranteral Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development